Cita APA

Papadimitropoulou, A., Vellon, L., Atlas, E., Van der Steen, T., Cuyàs, E., Verdura, S., . . . Lupu, R. (2020). Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer.

Citación estilo Chicago

Papadimitropoulou, Adriana, Luciano Vellon, Ella Atlas, Travis Van der Steen, Elisabet Cuyàs, Sara Verdura, Ingrid Espinoza, Javier Abel Menéndez Menéndez, y Ruth Lupu. Heregulin Drives Endocrine Resistance By Altering IL-8 Expression in ER-Positive Breast Cancer. 2020.

Cita MLA

Papadimitropoulou, Adriana, et al. Heregulin Drives Endocrine Resistance By Altering IL-8 Expression in ER-Positive Breast Cancer. 2020.